NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Cancer Proteomics Tumor Analysis Consortium Prospective Biospecimen Collection Protocol, Breast Cancer   Add to my SOP compendium

BRD ID: 301

Source: CPTAC Tier: SOP Number of times downloaded: 2386

Description

This document describes three options for the procurement of ductal and lobular breast cancer specimens, stage IIA-IIIC, to be used for proteomics or genomic analysis. The three tissue procurement procedures described are (i) tumor excision at lumpectomy/mastectomy, (ii) large-bore percutaneous tumor coring before lumpectomy/mastectomy, and (iii) large-bore percutaneous coring during port placement. Specimens are suitable for genomic or proteomic analysis. A procedure for the collection of peripheral venous blood prior to the administration of anesthesia is also included. Protocols are a product of the Clinical Proteomic Tumor Analysis Consortium (CPTAC; http://proteomics.cancer.gov/programs/cptacnetwork), which is sponsored by the National Cancer Institute's Office of Cancer Clinical Proteomics Research (http://proteomics.cancer.gov/).

Documents for Download

CPTAC_Breast_Procurement_Protocol_v1_9.pdf [Size: 228 KB]

Biospecimens
  • Tissue - Breast
  • Fluid - Blood
  • Fluid - Plasma
Diagnoses
  • Neoplastic - Carcinoma
  • Neoplastic - Normal Adjacent
Topics
  • Biospecimen Acquisition
  • Biospecimen Preservation

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • More...